Join us for a Nexus-KDIGO expert-led live webinar series designed to support clinicians in navigating the management of chronic kidney disease (CKD) and hypertension during a period of rapid scientific advancement.
Throughout this three-part program, clinical experts will explore the biological role of aldosterone in CKD progression and examine how validated assessment tools, such as the estimated glomerular filtration rate (eGFR) slope, can translate emerging evidence into real-world clinical practice. Participants will gain essential knowledge to support earlier identification of individuals with CKD and the development of personalized treatment strategies.
Schedule
Webinar 1: The role of aldosterone in kidney function decline in patients with CKD
David Wheeler & Adeera Levin
Monday 15 June 2026
12:00 EST (USA) / 18:00 CEST (Europe)
Webinar 2: Optimizing the use of assessment tools to improve patient outcomes: Insights from eGFR slope research
David Wheeler & Hiddo Lambers Heerspink
Wednesday 17 June 2026
12:00 EST (USA) / 18:00 CEST (Europe)
Webinar 3: Translating research into practice: Identifying opportunities to improve patient outcomes
David Wheeler, Adeera Levin & Hiddo Lambers Heerspink
Friday 19 June 2026
12:00 EST (USA) / 18:00 CEST (Europe)
Learning Objectives
Target Audience
Nephrologists and other healthcare professionals involved in the care of patients with CKD.
Goal Statement
The goal of this webinar series is to demonstrate how effective use of assessment tools and emerging therapeutic classes has the potential to influence clinical decision-making and enable earlier intervention and improved kidney and cardiovascular outcomes for patients.
Location
These webinars will be hosted via Zoom – a link will be shared with you upon confirmation of attendance either by emailing [email protected] or registering via this Nexus HE learning HUB event page.